img
Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study     
Yazarlar
Dr. Öğr. Üyesi Aslıhan YURTKAL Dr. Öğr. Üyesi Aslıhan YURTKAL
Kafkas Üniversitesi, Türkiye
Dr. Öğr. Üyesi Müjde CANDAY Dr. Öğr. Üyesi Müjde CANDAY
Kafkas Üniversitesi, Türkiye
Özet
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine disorder with significant metabolic implications, including an increased risk of cardiovascular diseases and diabetes. Kallistatin, a serine proteinase inhibitor with anti-inflammatory and antioxidative properties, has been identified as a potential biomarker for PCOS due to its role in modulating inflammation and oxidative stress. This prospective cohort study was conducted at a university hospital's gynecology clinic. It included 220 women diagnosed with PCOS and 220 healthy controls matched for age and body mass index. Kallistatin levels were quantitatively assessed using enzyme-linked immunosorbent assay (ELISA) techniques. Associations between kallistatin levels and clinical manifestations of PCOS, including hyperandrogenism and metabolic profiles, were examined. Kallistatin levels were significantly lower in patients with PCOS (2.65 ± 1.84 ng/mL) compared to controls (6.12 ± 4.17 ng/mL; < 0.001). A strong negative correlation existed between kallistatin levels and androgen concentrations (r = -0.782, = 0.035). No significant associations were found between kallistatin levels and insulin resistance or lipid profiles. The findings indicate that reduced kallistatin levels are closely associated with PCOS and could serve as a promising biomarker for its diagnosis. The specific correlation with hyperandrogenism suggests that kallistatin could be particularly effective for identifying PCOS subtypes characterized by elevated androgen levels. This study supports the potential of kallistatin in improving diagnostic protocols for PCOS, facilitating earlier and more accurate detection, which is crucial for effective management and treatment.
Anahtar Kelimeler
diagnostic biomarker | hyperandrogenism | inflammation | kallistatin | oxidative stress | polycystic ovary syndrome
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı Diagnostics
Dergi ISSN 2075-4418
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q1
Makale Dili İngilizce
Basım Tarihi 07-2024
Cilt No 14
Sayı 14
Sayfalar 1553 / 0
Doi Numarası 10.3390/diagnostics14141553
Makale Linki http://dx.doi.org/10.3390/diagnostics14141553
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Kallistatin as a Potential Biomarker in Polycystic Ovary Syndrome: A Prospective Cohort Study

Paylaş